体外诊断包装市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

2024 年全球体外诊断包装市场估值达 86 亿美元，预计 2025 年至 2034 年期间复合年增长率为 5.1%。主要驱动因素之一是新兴市场对在地化製造和包装解决方案的需求不断增加。这些地区的医疗保健基础设施正在快速发展，导致诊断测试数量增加，迫切需要确保这些测试完整性的包装解决方案。因此，越来越多的公司开始专注于包装创新，以满足这些发展中市场的特定需求。个人化医疗、即时诊断检测的趋势以及已开发地区人口老化日益加剧，进一步推动了对高品质 IVD 包装的需求。人们更加重视诊断测试的安全性和精确度，这进一步推动了这种成长。

就产品类型而言，市场分为管、瓶和小瓶、培养皿、封盖和其他包装解决方案。其中，到 2034 年，瓶子和小瓶部分预计将产生 40 亿美元的收入。它们的多功能性使其具有广泛的应用范围，从储存血液和尿液样本到包装分子和生化试剂。这种广泛的适用性使得瓶子和小瓶子在 IVD 行业中继续成为不可或缺的一部分。

IVD包装市场也看到来自各种终端使用者的需求，包括医院、实验室、学术机构等。其中，学术机构部分预计成长最快，2025 年至 2034 年期间的复合年增长率为 7%。学术机构在推动医学研究方面发挥关键作用，包括开发新的诊断测试、试剂和技术。随着研究活动的扩大，对维持生物样本和试剂的完整性和稳定性的专门包装解决方案的需求也日益增长。研发投资的激增和研究驱动计画的扩展只会增加对学术目的的先进封装解决方案的需求。

在北美，IVD包装市场占有相当大的份额，到2024年将占到整个市场的35%。随着人口老化加剧，对个人化医疗和即时诊断检测等先进诊断解决方案的需求不断增长，并继续推动市场扩张。随着医疗保健提供者和机构努力寻求更有效、更有效率的诊断解决方案，北美对高品质、专业化 IVD 包装的需求仍然是该地区市场成长的关键因素。

目录

第 1 章：方法论与范围

• 市场范围和定义
• 基础估算与计算
• 预测计算
• 资料来源
  • 基本的
  • 次要
    • 付费来源
    • 公共资源

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
  • 影响价值链的因素
  • 利润率分析
  • 中断
  • 未来展望
  • 製造商
  • 经销商
• 重要新闻及倡议
• 监管格局
• 衝击力
  • 成长动力
    • 诊断测试解决方案的需求不断增长
    • IVD 包装技术的进步
    • 新兴市场的医疗保健扩张
    • 对本地製造和包装的需求
    • 更重视永续包装解决方案
  • 产业陷阱与挑战
    • 专业包装解决方案成本高
    • 满足复杂的监管要求
• 成长潜力分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按产品，2021-2034 年

• 主要趋势
• 瓶子和小瓶
• 管
• 培养皿
• 闭包
• 其他的

第 6 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 糖尿病
• 传染病
• 心臟病学
• 自体免疫疾病
• 肿瘤学
• 药物检测
• 其他的

第 7 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 实验室
• 学术机构
• 其他的

第 8 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
• 中东及非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• Abdos Labtech
• Academy Medical Instruments
• AdvaCare Pharma
• Amcor
• Amrit Scientific
• Ajosha Bio Teknik
• Aptargroup
• Corning
• Focus Technology
• Fusion Biotech
• Globe Scientific
• Greiner Holding
• Kindly Group
• Labtech Disposables
• Narang Medical
• Oliver
• Peacock Industries
• VWR International
• Yuhuan Kangjia
• Zhuhai Ideal Biotech

The Global In-Vitro Diagnostics Packaging Market reached a valuation of USD 8.6 billion in 2024 and is estimated to grow at a CAGR of 5.1% from 2025 to 2034. The market's upward trajectory is driven by several factors. One of the primary drivers is the increasing demand for localized manufacturing and packaging solutions in emerging markets. These regions are seeing rapid advancements in healthcare infrastructure, resulting in an uptick in diagnostic tests and an urgent need for packaging solutions that ensure the integrity of these tests. As a result, more companies are focusing on packaging innovations that cater to the specific needs of these developing markets. The trend toward personalized medicine, point-of-care testing, and the growing aging population in developed regions further contribute to the demand for high-quality IVD packaging. This growth is further fueled by a greater focus on safety and precision in diagnostic testing.

In terms of product types, the market is segmented into tubes, bottles and vials, petri dishes, closures, and other packaging solutions. Of these, the bottles and vials segment is expected to generate USD 4 billion through 2034. These packaging solutions are essential in the IVD sector, providing crucial protection against contamination, moisture, and light, which helps preserve the stability and accuracy of diagnostic reagents and samples. Their versatility allows for a wide array of applications, from the storage of blood and urine samples to packaging molecular and biochemical reagents. This broad applicability continues to make bottles and vials indispensable in the IVD industry.

The IVD packaging market also sees demand from various end users, including hospitals, laboratories, academic institutions, and others. Among these, the academic institutions segment is projected to grow the fastest, with a CAGR of 7% between 2025 and 2034. This growth can be attributed to the increasing investments in research and development in diagnostic technologies. Academic institutions play a pivotal role in advancing medical research, including the development of new diagnostic tests, reagents, and techniques. As research activities expand, the need for specialized packaging solutions that maintain the integrity and stability of biological samples and reagents grows. The surge in R&D investments and the expansion of research-driven initiatives will only intensify the demand for advanced packaging solutions tailored for academic purposes.

In North America, the IVD packaging market holds a significant share, accounting for 35% of the total market in 2024. This dominance is largely driven by the region's leadership in medical technology innovation, with considerable investments in research and development, especially in diagnostic technologies. The rising demand for advanced diagnostic solutions, such as personalized medicine and point-of-care testing, coupled with the aging population, continues to fuel market expansion. As healthcare providers and institutions strive for more effective and efficient diagnostic solutions, the need for high-quality, specialized IVD packaging in North America remains a key factor in the region's market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2022-2034

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Key news & initiatives
• 3.3 Regulatory landscape
• 3.4 Impact forces
  • 3.4.1 Growth drivers
    • 3.4.1.1 Rising demand for diagnostic test solutions
    • 3.4.1.2 Advancements in IVD packaging technologies
    • 3.4.1.3 Expansion of healthcare in emerging markets
    • 3.4.1.4 Demand for local manufacturing and packaging
    • 3.4.1.5 Increasing focus on sustainable packaging solutions
  • 3.4.2 Industry pitfalls & challenges
    • 3.4.2.1 High costs of specialized packaging solutions
    • 3.4.2.2 Navigating complex regulatory requirements
• 3.5 Growth potential analysis
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product, 2021-2034 (USD Million & Kilo Tons)

• 5.1 Key trends
• 5.2 Bottles and vials
• 5.3 Tubes
• 5.4 Petri dishes
• 5.5 Closures
• 5.6 Others

Chapter 6 Market Estimates & Forecast, By Application, 2021-2034 (USD Million & Kilo Tons)

• 6.1 Key trends
• 6.2 Diabetes
• 6.3 Infectious diseases
• 6.4 Cardiology
• 6.5 Autoimmune diseases
• 6.6 Oncology
• 6.7 Drug testing
• 6.8 Others

Chapter 7 Market Estimates & Forecast, By End Use, 2021-2034 (USD Million & Kilo Tons)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Laboratories
• 7.4 Academic institutes
• 7.5 Others

Chapter 8 Market Estimates & Forecast, By Region, 2021-2034 (USD Million & Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 UK
  • 8.3.2 Germany
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abdos Labtech
• 9.2 Academy Medical Instruments
• 9.3 AdvaCare Pharma
• 9.4 Amcor
• 9.5 Amrit Scientific
• 9.6 Ajosha Bio Teknik
• 9.7 Aptargroup
• 9.8 Corning
• 9.9 Focus Technology
• 9.10 Fusion Biotech
• 9.11 Globe Scientific
• 9.12 Greiner Holding
• 9.13 Kindly Group
• 9.14 Labtech Disposables
• 9.15 Narang Medical
• 9.16 Oliver
• 9.17 Peacock Industries
• 9.18 VWR International
• 9.19 Yuhuan Kangjia
• 9.20 Zhuhai Ideal Biotech